Status:
COMPLETED
Medication Review in Patients on Anti-parkinson Therapy
Lead Sponsor:
South Glasgow University Hospitals NHS Trust
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson's disease is incorrect and to supervise and clinically monitor the withdrawal of anti-par...
Detailed Description
Step 1 - Practice based pharmacist and medical review using database search for the following: * Anti-parkinson drug therapy (excluding anticholinergic monotherapy). * Disease codes to identify Parki...
Eligibility Criteria
Inclusion
- Patients on anti-parkinson medication who:
- Have been on monotherapy for a prolonged period, or
- Use anti-parkinson medications intermittently, or
- Do not have the expected change in medication over time in keeping with degenerative Parkinson's disease.
Exclusion
- Patients on anti-parkinson medication for reasons other than Parkinson's disease.
- Patients with significant co-morbidity (end stage liver, cardiac or renal disease).
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00443768
Start Date
October 1 2006
End Date
August 1 2008
Last Update
February 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern General Hospital
Glasgow, Scotland, United Kingdom, G51 4TF